Asia-Pacific Breast Biopsy Devices Market, By Product (Biopsy Needles, Biopsy Tables, Biopsy Wires, Guidance Systems, Others), Technique Type (Fine Needle Aspiration Biopsy, Core Needle Biopsy, Biopsy Markers, MRI-Guided Core Needle Biopsy, Surgical Biopsy, Wire Localization, Sentinel Node Biopsy), Guidance Technology (Fine Ultrasound-Guided, Mammography-Guided Magnetic Resonance, CT-Guided Biopsy, Other Image-Guided Breast Biopsy), End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other), Country (Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast to 2028
Market Analysis and Insights: Asia-Pacific Breast Biopsy Devices Market
Asia-Pacific breast biopsy devices market is expected to witness market growth at a rate of 9.1% in the forecast period of 2021 to 2028. Data Bridge Market Research report on Asia-Pacific breast biopsy devices market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in healthcare sector is escalating the growth of Asia-Pacific breast biopsy devices market.
Breast biopsy devices refer to the medical devices that are utilized for breast biopsy procedures. The procedure relates to the surgical extraction of tissue or fluid for the purpose of detection and examination of any feasible disease. To verify for the existence of breast cancer, the tissue taken is examined under microscopes.
The increase in the prevalence of breast cancer among population across the globe acts as one of the major factors driving the growth of breast biopsy devices market. The rise in demand for minimally invasive and non-invasive procedures owning to their advantages such as less pain and faster recovery, and surge in number of breast cancer screening programs accelerate the market growth. The growth in awareness regarding early detection of breast cancer and availability of various types of technologies and products, such as needle-based biopsy guns, biopsy guiding systems, and vacuum-assisted devices further influence the market. Additionally, surge in healthcare expenditure, increase in public–private investments and funding and improved reimbursement scenario positively affects the breast biopsy devices market. Furthermore, emergence of liquid biopsy and promising clinical trials extend profitable opportunity to the market players in the forecast period of 2021 to 2028.
On the other hand, risk of infections associated with the use of biopsy needles, and stringent regulatory approval procedures are expected to obstruct the market growth. Lack of resources in developing countries and concerns regarding product recalls are projected to challenge the breast biopsy devices market in the forecast period of 2021-2028.
This Asia-Pacific breast biopsy devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Asia-Pacific breast biopsy devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Asia-Pacific Breast Biopsy Devices Market Scope and Market Size
The Asia-Pacific breast biopsy devices market is segmented on the basis of product, technique type, guidance technology and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product, the breast biopsy devices market is segmented into biopsy needles, biopsy tables, biopsy wires, guidance systems and others.
- On the basis of technique type, the breast biopsy devices market is segmented into fine needle aspiration biopsy, core needle biopsy, biopsy markers, MRI-guided core needle biopsy, surgical biopsy, wire localization, and sentinel node biopsy.
- On the basis of guidance technology, the breast biopsy devices market is segmented into fine ultrasound-guided, mammography-guided magnetic resonance, CT-guided biopsy, and other image-guided breast biopsy.
- On the basis of end user, the breast biopsy devices market is segmented into hospitals, ambulatory surgical centers, diagnostic centers and other.
Asia-Pacific Breast Biopsy Devices Market Country Level Analysis
The Asia-Pacific breast biopsy devices market is analyzed and market size insights and trends are provided by country, product, technique type, guidance technology and end user as referenced above.
The countries covered in the Asia-Pacific breast biopsy devices market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).
Asia-Pacific is expected to witness significant growth during the forecast period of 2021 to 2028 due to the increase in prevalence of breast cancer, growing number of awareness programs for the early detection of breast cancer, and the high government spending in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Asia-Pacific breast biopsy devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Asia-Pacific breast biopsy devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Asia-Pacific breast biopsy devices market. The data is available for historic period 2011-2019.
Competitive Landscape and Asia-Pacific Breast Biopsy Devices Market Share Analysis
Asia-Pacific breast biopsy devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, regional presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to breast Asia-Pacific biopsy devices market.
The major players covered in the Asia-Pacific breast biopsy devices market report are Stryker, BD, Hologic Inc., Devicor Medical Products Inc., F. Hoffmann-La Roche Ltd, Cook, Siemens, Medtronic, Scion Medical Technologies LLC, ARGON MEDICAL, Danaher, Benetec, Cigna, United Medical Systems Inc., SOMATEX Medical Technologies GmbH, Trivitron Healthcare, Johnson & Johnson Services Inc., Boston Scientific Corporation, Olympus Corporation, FUJIFILM Holdings Corporation, GENERAL ELECTRIC, Cardinal Health, and B. Braun Melsungen AG, among other. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-